Back
Opus Genetics Quote, Financials, Valuation and Earnings
Sponsored
IRD
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
37
IRD
Opus Genetics
Last Price:
1.07
Seasonality Move:
3.61%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.Opus Genetics Price Quote
$1.07
-0.02 (-1.83%)
(Updated: November 14, 2024 at 5:55 PM ET)
Opus Genetics Key Stats
Sell
37
Opus Genetics (IRD)
is a Sell
Day range:
$1.07 - $1.15
52-week range:
$1.07 - $3.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.64
P/B ratio:
0.73%
Volume:
228.1K
Avg. volume:
146.2K
1-year change:
-62.15%
Market cap:
$29.6M
Revenue:
$19M
EPS:
$-0.55
How Much Does Opus Genetics Make?
-
How Much Are Opus Genetics's Sales Annually?
IRD Revenues are $19M -
How Much Profit Does Opus Genetics's Make A Year?
IRD net income is -$10M
Is Opus Genetics Growing As A Company?
-
What Is Opus Genetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.7% -
What Is Opus Genetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Opus Genetics Stock Price Performance
-
Did Opus Genetics Stock Go Up Last Month?
Opus Genetics share price went down by -10.66% last month -
Did IRD's Share Price Rise Over The Last Year?
IRD share price fell by -62.15% over the past 1 year
What Is Opus Genetics 52-Week High & Low?
-
What Is Opus Genetics’s 52-Week High Share Price?
Opus Genetics has traded as high as $3.40 over the past 52 weeks -
What Is Opus Genetics’s 52-Week Low Share Price?
Opus Genetics has traded as low as $1.07 over the past 52 weeks
Opus Genetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Opus Genetics?
-
How Much Debt Does Opus Genetics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Opus Genetics Have?
Cash and short term investments quarterly total is $41.4M -
What Is Opus Genetics’s Book Value Per Share?
Book value per share is 1.56
Is Opus Genetics Cash Flow Positive?
-
What Is IRD Cash Flow From Operations?
Cash flow from operations (TTM) is -$11.5M -
What Is Opus Genetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.9M -
What Is Opus Genetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Opus Genetics Return On Invested Capital
-
Is Management Doing A Good Job?
IRD return on invested capital is -31.4% -
What Is Opus Genetics Return On Assets?
ROA measures how assets are converting to revenues and is -28.41% -
What Is IRD Return On Equity?
ROE is a measure of profitability and is -31.4%
Opus Genetics Earnings Date & Stock Price
-
What Is Opus Genetics's Stock Price Today?
A single share of IRD can be purchased today for 1.09 -
What Is Opus Genetics’s Stock Symbol?
Opus Genetics trades on the nasdaq under the ticker symbol: IRD -
When Is Opus Genetics’s Next Earnings Date?
The next quarterly earnings date for Opus Genetics is scheduled on March 7, 2025 -
When Is IRD's next ex-dividend date?
Opus Genetics's next ex-dividend date is November 15, 2024 -
How To Buy Opus Genetics Stock?
You can buy Opus Genetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Opus Genetics Competitors
-
Who Are Opus Genetics's Competitors?
Below is a list of companies who compete with Opus Genetics or are related in some way:
Opus Genetics Dividend Yield
-
What Is IRD Dividend Yield?
Opus Genetics’s dividend yield currently is 0% -
What Is Opus Genetics’s Payout Ratio?
Opus Genetics’s payout ratio is 0% -
When Did Opus Genetics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Opus Genetics’s Dividend Per Share?
Opus Genetics pays a dividend of $0.00 per share
Opus Genetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -27.94% |
Revenue: | -69.73% | 68.41% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 12.00 |
Upside from Last Price: | 1000.92% |